These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21209720)

  • 1. Lung cancer stem cell: new insights on experimental models and preclinical data.
    Rivera C; Rivera S; Loriot Y; Vozenin MC; Deutsch E
    J Oncol; 2011; 2011():549181. PubMed ID: 21209720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer stem cells: a new target for lung cancer treatment].
    Rivera S; Rivera C; Loriot Y; Hennequin C; Vozenin MC; Deutsch E
    Cancer Radiother; 2011 Aug; 15(5):355-64. PubMed ID: 21664165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells in small cell lung cancer.
    Codony-Servat J; Verlicchi A; Rosell R
    Transl Lung Cancer Res; 2016 Feb; 5(1):16-25. PubMed ID: 26958490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer stem cells: a biological and clinical perspective.
    Koren A; Motaln H; Cufer T
    Cell Oncol (Dordr); 2013 Jul; 36(4):265-75. PubMed ID: 23900738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer.
    Kitamura H; Okudela K; Yazawa T; Sato H; Shimoyamada H
    Lung Cancer; 2009 Dec; 66(3):275-81. PubMed ID: 19716622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
    Heng WS; Gosens R; Kruyt FAE
    Biochem Pharmacol; 2019 Feb; 160():121-133. PubMed ID: 30557553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
    Dzobo K; Ganz C; Thomford NE; Senthebane DA
    OMICS; 2021 Feb; 25(2):81-92. PubMed ID: 33170084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
    Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
    J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes.
    Luanpitpong S; Wang L; Castranova V; Rojanasakul Y
    Part Fibre Toxicol; 2014 May; 11():22. PubMed ID: 24885671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering cancer stem-like cells from normal human lung epithelial cells.
    Sasai K; Takao-Rikitsu E; Sukezane T; Yanagita E; Nakagawa H; Itoh-Yagi M; Izumi Y; Itoh T; Akagi T
    PLoS One; 2017; 12(4):e0175147. PubMed ID: 28380052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stemness and plasticity of lung cancer cells: paving the road for better therapy.
    Luo J; Zhou X; Yakisich JS
    Onco Targets Ther; 2014; 7():1129-34. PubMed ID: 25018639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.
    Chan TS; Shaked Y; Tsai KK
    Front Oncol; 2019; 9():688. PubMed ID: 31417869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
    Parte SC; Batra SK; Kakar SS
    J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers and targeted therapy for cancer stem cells.
    Liu Y; Wang H
    Trends Pharmacol Sci; 2024 Jan; 45(1):56-66. PubMed ID: 38071088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.